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Abstract
The ventral tegmental area (VTA) is widely implicated in drug addiction and other psychiatric disorders. This brain region is
densely populated by dopaminergic (DA) neurons and also contains a sparse population of c-aminobutyric acid (GABA)ergic
cells that regulate the activity of the principal neurons. Therefore, an in-depth knowledge of the organization of VTA
GABAergic circuits and of the plasticity induced by drug consumption is essential for understanding the mechanisms by
which drugs induce stable changes in brain reward circuits. Using immunohistochemistry, we provide a detailed description
of the localization of major GABAA and GABAB receptor subunits in the rat VTA. We show that DA and GABAergic cells
express both GABAA and GABAB receptors. However VTA neurons differ considerably in the expression of GABAA receptor
subunits, as the a1 subunit is associated predominantly with non-DA cells, whereas the a3 subunit is present at low levels in
both types of VTA neurons. Using an unbiased stereological method, we then demonstrate that a1-positive elements
represent only a fraction of non-DA neurons and that the ratio of DA and non-DA cells is quite variable throughout the
rostro-caudal extent of the VTA. Interestingly, DA and non-DA cells receive a similar density of perisomatic synapses,
whereas axo-dendritic synapses are significantly more abundant in non-DA cells, indicating that local interneurons receive
prominent GABAergic inhibition. These findings reveal a differential expression of GABA receptor subtypes in the two major
categories of VTA neurons and provide an anatomical basis for interpreting the plasticity of inhibitory circuits induced by
drug exposure.
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Introduction
The ventral tegmental area (VTA) is a midbrain region critically
involved in natural reward and drug addiction [1,2]. Dopamine
(DA)-releasing neurons of the VTA send projections to limbic
forebrain structures, including the prefrontal cortex, amygdala and
nucleus accumbens. All addictive drugs studied so far exert their
actions by increasing DA levels in the VTA target regions [3]. In
addition, addictive drugs trigger synaptic plasticity in the VTA,
leading to persistent modifications of neural circuits that are
believed to underlie addictive behaviours [4–8].
In addition to DA cells, the VTA is populated by GABAergic
neurons that provide an important regulatory influence over the
activity of DA neurons, and also send projections to a variety of
brain regions [9–13]. A population of GABAergic cells appears to
be concentrated in the caudalmost tier of the VTA, the so-called
tail of the VTA [14]. These neurons are activated by exposure to
psychostimulants and to other drugs [14–17], and send GABAer-
gic projections to the VTA and the substantia nigra pars compacta
[18,19]. Moreover, a recent optogenetic study demonstrated that a
significant number of GABAergic, medium spiny neurons of the
nucleus accumbens project back to the VTA, where they target
non-DA neurons [20]. Therefore, it appears that different types of
VTA and non-VTA neurons provide GABAergic inhibition of DA
cells.
There is accumulating evidence that changes in GABAergic
inhibition contribute to circuit modifications induced by several
types of drugs of abuse. Specifically, opioids, cannabinoids, and c-
hydroxybutyrate affect the excitability of DA cells by suppressing
GABA release from VTA interneurons [3,21–27]. Notably,
chronic exposure to opiates can dynamically regulate GABAAR
signaling in neurons of the VTA and direct VTA output through
separate brain reward systems [28]. Similarly cocaine, a drug that
mainly affects dopamine transporters, decreases GABAergic
inhibition and facilitates LTP in VTA neurons [5]. It has also
been reported that benzodiazepines, that are allosteric modulators
of GABAARs widely used in the treatment of anxiety, insomnia
and seizures [29], increase dopamine levels and cause drug
reinforcement through disinhibition of DA cells [30,31]. Long-
term exposure to benzodiazepines results in tolerance and
dependence, which increase their potential for abuse and limit
their clinical utility [32,33]. Interestingly, application of the
GABAAR agonist muscimol in the VTA can either increase or
decrease DA levels in the nucleus accumbens, likely reflecting
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e46250
Table 1. Primary antibodies used in this study.
Antibody Immunogen Source – Cat. Number - Species Dilution
Tyrosine hydroxilase (TH) TH purified from rat PC12 cells Immunostar, no. 22941
mouse monoclonal
1:4000
GABAAR a1 Rat N-terminal peptide amino acids 1–16 H. Mohler and J.-M. Fritschy (Institute of Pharmacology and
Toxicology, University of Zurich, Switzerland)
Guinea pig polyclonal
1:5000
GABAAR a1 Rat N-terminal peptide amino acids 1–16 H. Mohler and J.-M. Fritschy
Rabbit polyclonal
1:5000
GABAAR a3 Rat N-terminal peptide amino acids 1–15 H. Mohler and J.-M. Fritschy
Guinea pig polyclonal
1:4000
NeuN Purified cell nuclei from mouse brain Chemicon/Millipore, code MAB377
Mouse monoclonal
1:5000
GABABR1 Synthetic peptide from rat GABAB receptor Chemicon, code AB1531
Guinea pig polyclonal
1:4000
Vesicular GABA transporter (VGAT) Synthetic peptide AEPPVEGDIHYQR (aa 75–87
in rat) coupled to keyhole limpet hemocyanin
via an added N- terminalcysteine
Synaptic Systems, no. 131003
Rabbit polyclonal, affinity purified
1:3000
doi:10.1371/journal.pone.0046250.t001
Figure 1. Differential distribution of a1- and a3-GABAARs in DA and non-DA cells. (A) Representative image showing that labeling for
GABAAR a1 is generally not associated with TH-positive neurons. (B) Triple labeling showing that TH-positive and a1-positive neurons are labeled for
NeuN. (C) Double labeling for TH and GABAAR a1 in a section processed with the brief-fixation protocol. Arrows indicate a1-immunolabeled clusters
at the surface of a TH-positive neuron. (D,E) Double labeling for GABAAR a3 and TH on briefly-fixed tissue. Labeling for the a3 subunit (arrows) is
present both in TH-positive (D) and TH-negative cells (E). (F,G) Confocal images from triple-labeled sections showing co-localization of the a1 and a3
subunits in TH-positive (F) and TH-negative cells (G). The boxed areas are enlarged and shown as tridimensional projections. Scale bars: A,B = 30 mm.
C–E= 12 mm. F,G= 10 mm (inset = 2 mm).
doi:10.1371/journal.pone.0046250.g001
GABAergic Circuits of the Ventral Tegmental Area
PLOS ONE | www.plosone.org 2 October 2012 | Volume 7 | Issue 10 | e46250
dose-dependent effects on GABAARs expressed by DA cells and
GABAergic interneurons [9–11,23].
The present study was undertaken to ameliorate our under-
standing of the organization of GABAergic synaptic circuits of the
rat VTA. Using immunohistochemistry, we show that there is a
largely differential expression of GABAARs containing either the
a1 or the a3 subunit in DA and non-DA cells, whereas GABABRs
are expressed in both cell types. We also compare GABAergic
innervation in DA and non-DA cells, and we provide a
quantitative estimate of these two neuronal populations using
unbiased stereology with an optical disector.
Materials and Methods
Tissue preparation and immunohistochemistry
The experiments described in this study were performed on
adult male Sprague–Dawley CD rats raised under standard
laboratory conditions with unrestricted access to food and water.
The experimental procedures were approved by the Italian
Ministry of Health and by the Bioethic Committee of Turin
University in accordance with national (Legislative Decree 116/92
and law n. 413/1993) and international (Directive 86/609/EEC
and the recommendation 2007/526/EC from European commu-
nity) laws and policies. Animals were anaesthetised with an
intraperitoneal injection of chloral hydrate and transcardially
perfused with ice cold formaldehyde (4% in 0.1 M phosphate
buffer – PB, pH 7.4). After perfusion, the brains were dissected
and kept in the same fixative at 4uC overnight. After several
washes in PB, brains were cryoprotected by immersion in 10%,
20%, and 30% sucrose solutions, cut in 16-mm or 30-mm sections
with a cryostat and stored at 220uC. In order to analyze the
subcellular localization of GABAAR subunits we also used a brief-
fixation protocol that has been optimized for in situ detection of
postsynaptic molecules [34]. Briefly, the rat midbrain was cut
manually in coronal slices (,1 mm) that were fixed by immersion
in 4% formaldehyde for 30 minutes (for details see ref. [35]). The
sections were then cryoprotected in sucrose (10%, 20% and 30%)
and sectioned with a cryostat at 16 mm.
For immunofluorescence, sections were first blocked with a
solution containing 10% normal goat serum (NGS) and 0.05%
Triton X-100 in phosphate-buffered saline (PBS; pH 7.4) and then
incubated overnight with combinations of two or three primary
antibodies raised in different species (see Table 1 for antibody
specification). The sections were then rinsed in PBS and incubated
with the appropriate secondary antibodies raised either in goat or
in donkey and conjugated to Alexa 488 (Molecular Probes,
Eugene, Oregon) or the cyanines Cy3 and Cy5 (Jackson
ImmunoResearch, West Grove, PA). Finally, the sections were
rinsed and coverslipped with Dako fluorescence mounting
medium (Dako Italia, Italy).
Microscopy and data analysis
For cell density quantification six coronal sections (30 mm) of rat
midbrain derived from a 1:6 series were assigned to three VTA
rostrocaudal levels: rostral VTA (bregma 25.00 to 25.40 mm),
middle VTA (bregma 25.40 to 25.80 mm) and caudal VTA
(bregma 25.80 to 26.20 mm). Quantification of cell densities was
done at these three rostrocaudal levels in the major subnuclei of
the VTA (PBP, PN, IF, RLi, CLi), according to Paxinos and
Watson [36]. For each rostrocaudal level, the sampling regions
were eight in the PBP and PN, and four in the other VTA
subnuclei (RLi, IF, and CL). Each sampling region was
represented by a Z-stack composed of four confocal sections
(102461024 pixels corresponding to 230 mm6230 mm) spaced
2.50 mm. Confocal images were acquired with a laser scanning
confocal microscope (Zeiss LSM5 Pascal) with a 406 oil-
immersion objective using the multi-track mode. We first
calculated the volumetric density of NeuN-positive cells by
counting cells that were present in the second (lookup) section
but not in the fourth (reference) section of each confocal stack.
Subsequently, we assessed the degree of colocalization of NeuN
with TH and GABAAR a1 in the counted cells.
To calculate the density of VGAT boutons contacting TH- and
a1-positive cells, we acquired confocal images at high resolution
with a 1006oil-immersion objective (1.4 NA) and the pinhole set
at 1 Airy unit. Each confocal image was composed by four optical
sections spaced 0.37 mm. A minimum of ten pictures derived from
the rostral and the caudal VTA were used. On every cell we
estimated the linear density of synaptic appositions by calculating
manually the number of clusters in direct contact with the cell
body or the dendritic profiles. All analyses were done with the
NIH ImageJ software.
Statistical Analysis
Statistical analysis was done by two-way ANOVA using SPSS
12.0 software (SPSS Inc., Chicago, IL). Significance threshold was
set at p,0.05. All data are presented as means 6 SEM.
Results
The GABAAR a1 subunit is mainly expressed by non-DA
cells whereas the a3 subunit is expressed by both DA
and non-DA cells
We initially labeled VTA sections with antibodies directed
against different GABAAR subunits (a1, a2, a3, a4, a5, d). We
observed prominent labeling for the GABAAR a1 subunit and
moderate labeling for GABAAR a3, whereas the other subunits
were undetectable or expressed at very low levels (not shown).
With few exceptions, these observations are in good agreement
with previous immunohistochemical reports [37–39], and indicate
that GABAARs containing the a1 and/or a3 subunits are
predominant in the VTA.
We therefore investigated the expression of these GABAAR
subunits in relation to the two major neuronal populations of the
VTA, DA cells and non-DA cells. Using triple immunofluores-
cence for TH, GABAAR a1 and the neuronal marker NeuN in
perfused tissue, we found that the a1 subunit was mainly expressed
by non-DA cells (Fig. 1A,B), although occasionally we observed
TH-positive elements that were also labeled for GABAAR a1. We
also used a more sensitive immunofluorescence protocol (see
Materials and Methods), to determine whether DA cells express
the a1 subunit. Using this approach, found that a1-positive
clusters decorated only occasionally the surface of TH-positive
cells (Fig. 1C), although in this case we could not estimate the
number of DA cells expressing GABAAR a1, nor the density of
GABAAR a1-positive clusters on individual neurons. These data
are in agreement with previous observations in the mouse VTA
[31], and indicate that TH-positive DA neurons do not usually
contain a1 GABAARs.
We then analyzed the distribution of the GABAAR a3 subunit.
Given the low fluorescence signals in perfused tissue (not shown),
we labeled sections processed according to the weak-fixation
protocol, that affords higher sensitivity. Double labelling for
GABAAR a3 and TH showed that the a3 subunit was expressed
by DA cells (Fig. 1D). However, there were also cases in which
TH-negative neurons were decorated by a3-positive clusters
(Fig. 1E), suggesting that the a3 subunit was expressed also by a
subset of non-DA cells. Triple labelling for TH, GABAAR a1 and
GABAergic Circuits of the Ventral Tegmental Area
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GABAAR a3 showed that the a1 and a3 subunits co-existed at the
level of individual clusters in both DA and non-DA cells
(Fig. 1F,G). Also in this case, we did not perform a quantitative
analysis of colocalization due to the inherent difficulties associated
with this kind of examination. However, these data reveal a
complex subunit composition of GABAARs expressed by VTA
neurons.
DA and non-DA cells in the VTA
We next performed a cell density analysis in the main subnuclei
of the VTA (Fig. 2A). We applied a stereological method with an
optical disector in sections triple labeled for TH, GABAAR a1 and
NeuN to determine the volumetric density of NeuN-positive
neurons, and we then determined the ratio of NeuN-positive cells
that were also labeled for TH and/or the a1 subunit (Table 2). In
Figure 2. Quantification of TH-positive and a1-positive neurons in the VTA. (A) Schematic diagrams of the VTA subnuclei at rostral (Bregma
25.0 to25.4 mm), middle (Bregma25.4 to 25.8 mm) and caudal (Bregma25.8 to 26.2 mm) VTA levels as shown in coronal sections (from Paxinos
and Watson, ref. [36]). The boxed areas indicate the position of the sampling fields utilized for cell density quantification (2306230 mm). PBP,
parabrachial nucleus; PN, paranigral nucleus; IF, interfascicular subnucleus; RLi, rostral linear nucleus; CLi, caudal linear nucleus. (B) Relative
abundance of VTA neurons in the parabrachial (PBP) and paranigral (PN) nuclei at different rostro-caudal levels. Four neuronal poulations of NeuN-
positive cells were identified: TH-positive (green), a1-positive (red), TH/a1-positive (blue) and TH/a1-negative (yellow). (C) Relative abundance of the
same neuronal populations in the medial VTA subnulcei. Data represent the mean 6 SEM of 3 rats.
doi:10.1371/journal.pone.0046250.g002
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the more lateral subnuclei of the VTA (PBP and PN), DA cells
accounted for approximately 60–70% of the total neuronal
population, with slightly higher values in the middle VTA
compared with the rostral and caudal subdivisions (Fig. 2B). In
contrast, the percentage of a1-positive cells ranged from 17 to 25,
with a rostro-caudal trend opposite to that of DA neurons,
implying that the TH/a1 ratio was higher in the middle VTA and
then decreased at more rostral and caudal levels (Fig. 2B).
Interestingly, a substantial number of NeuN-positive neurons was
labeled for neither TH nor GABAAR a1 (Fig. 2B and Table 2),
suggesting that non-DA neurons can be subdivided in two distinct
subgroups based on whether they express or not the a1 subunit.
The situation in the medial VTA subnuclei was more
heterogeneous. A particularly low density of a1-positive cells was
observed in the IF and CLi, whereas the RLi was characterized by
a rather low quantity of TH-positive neurons and an unusually
large percentage of a1-positive cells as well as cells that were
neither a1-positive nor TH-positive (Fig. 2C and Table 2). In all
the VTA subregions analyzed the percentage of cells double-
labeled for TH and GABAAR a1 was very low, as noted above.
Organization of GABAergic inputs in DA cells and a1-
positive cells
The results reported above suggest that DA cells express
relatively low amounts of GABAARs as compared to non-DA cells.
We therefore investigated whether this difference was correlated
with a difference in the density of GABAergic inputs between the
two cell types. We used an antiserum against the vesicular GABA
transporter (VGAT) to identify GABAergic axon terminals
contacting TH-positive and a1-positive cells in sections from
perfused brains. We found a similar density of perisomatic contacts
in the two cell populations, both in the rostral VTA and in the
caudal VTA (Fig. 3A,B). In contrast, there was a higher density of
axo-dendritic contacts in a1-positive cells compared with TH-
positive cells in both VTA subregions (Fig. 3C,D). These data
suggest that non-DA cells receive a higher amount of GABAergic
synapses on their dendrites compared to DA cells.
GABABRs are expressed by both DA cells and non-DA
cells
We then used an antibody against the obligatory GABABR1
subunit [40,41] to investigate the expression of GABABRs in the
two neuronal populations of the VTA. We found labeling for
GABABR1 in practically all cells that were positive for either TH
or GABAAR a1 (Fig. 4). The immunoreactivity was localized in
neuronal perikarya and also extended in some dendritic profiles
that were TH-positive. In contrast, a1-positive dendrites were
generally unlabeled for GABABR1 (Fig. 4). These data indicate
that GABABRs are expressed by both DA cells and non-DA cells,
and suggest the existence of differences in subcellular distribution
between these two cell populations.
Discussion
In this study we show that there is a differential expression of
GABAAR subtypes in DA and non-DA cells of the rat VTA. While
GABAARs containing the a1 subunit are mainly expressed by
non-DA cells, the a3 subunit is expressed at lower levels by both
DA and non-DA cells. In addition, both populations of neurons
appear to contain GABABRs. Our results are in agreement with a
recent study of the mouse VTA, in which GABAAR a1 and
GABAAR a3 were found to be largely segregated in TH-positive
and GAD67-GFP-positive cells, respectively [31]. However, our
study differs from the previous one mainly because we identified a
population of NeuN-positive cells that were neither TH-positive
nor a1-positive, suggesting that labeling for the a1 subunit
identifies only a subset of non-DA neurons.
By combining labeling for TH, GABAAR a1 and NeuN, we
estimated the ratio of DA and non-DA cells in different subnuclei
of the VTA (Fig. 2). There have been several previous attempts to
quantify the population of DA and non-DA cells in the VTA,
however a comparison of the results is not simple due to the
different methodologies and the different sampling procedures
used in different studies. The overall density of DA cells reported
here (Table 2) is in line with another investigation in which the
density of TH-positive neurons was estimated using an unbiased
optical fractionator [42]. Three main conclusions can be derived
from the analysis of the data represented in Table 2. First, the ratio
of DA and non-DA cells is quite variable throughout the VTA
rostro-caudal extent. In particular, the density of TH-positive cells
is considerably lower in the rostral VTA as compared with the
middle and caudal subdivisions, a conclusion that is consistent with
previous observations reporting greater numbers of DA neurons in
more caudal subregions of the VTA [43–45]. It is likely that the
relatively low density of TH-positive elements in the RLi
contributed significantly to the uneven rostro-caudal distribution
of DA neurons observed here. Second, non-DA cells account for
30–35% of neurons of the middle and caudal VTA, with even
higher values (56%) in the rostral subdivision. Again, this estimate
agrees quite well with previous reports according to which at least
one third of VTA neurons are non-DA [43,45,46]. Finally, our
results indicate that non-DA cells fall into a1-positive and a1-
negative subtypes, which account for approximately 17% and 23%
of the entire neuronal population of the VTA (Table 2). It is
tempting to speculate that a1-positive and a1-negative cells may
Table 2. Stereological estimate of neuronal populations of
the rat VTA.
Density (cells/mm3)6103
TH-positive a1-positive
TH-negative
a1-negative
TH-positive
a1-positive
Rostral PBP 12.561.3 5.460.6 4.060.6 0.160.1
Middle PBP 8.261.2 2.060.4 1.760.5 0.160.0
Caudal PBP 6.660.6 3.160.4 1.460.3 0.360.1
Rostral PN 12.162.5 5.161.0 2.661.1 0.360.1
Middle PN 15.361.1 2.760.5 3.160.1 0.360.1
Caudal PN 13.262.9 4.461.4 5.762.0 0.060.0
RLi 5.661.3 6.360.9 6.861.7 0.460.2
IF 25.063.1 2.960.8 9.762.0 0.760.2
CLi 25.562.4 2.660.9 6.960.4 0.560.3
Rostral VTA 10.460.5
(43%)
6.560.8
(26.9%)
7.160.8
(29.3%)
0.260.1
(0.8%)
Middle VTA 16.361.4
(70.3%)
2.160.6
(9.1%)
4.461.2
(18.9%)
0.460.2
(1.7%)
Caudal VTA 15.160.7
(64.3%)
3.460.9
(14.4%)
4.760.7
(20%)
0.360.1
(1.3%)
Total VTA 13.960.6
(58.9%)
4.060.1
(16.9%)
5.460.8
(22.9%)
0.360.1
(1.3%)
The values of rostral, middle and caudal VTA have been obtained averaging the
values of all the subnuclei at each individual rostro-caudal level. Percentage
values are referred to all NeuN-positive cells counted in the corresponding
region. Values are means 6 S.E.M. of 3 rats.
doi:10.1371/journal.pone.0046250.t002
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correspond to functionally distinct subtypes of non-DA neurons,
including a population of so-called tertiary cells that have a distinct
pharmacological profile [45,47]. According to Cameron et al.
[47], tertiary cells represent 27.4% of the neuronal population of
the guinea pig VTA, a percentage that is close to the one reported
here for non-DA a1-negative neurons. Further studies will have to
evaluate the expression of the a1 subunit as a possible molecular
signature for a specific population of VTA non-DA neurons.
The neurochemical identity of the two subtypes of non-DA cells
identified in the present study remains poorly characterized. It is
likely that most of the non-DA cells are GABAergic neurons. In
fact, a quantitative study based on unbiased stereology reported
that 35% of all cells in the rat VTA are GABAergic [46]. This is
also consistent with the idea that the majority of VTA neurons are
either DA or GABAergic [21,48]. However, a recent investigation
in GAD67-GFP mice showed that TH-positive neurons are five
times more abundant than GAD-GFP cells [48]. The reasons for
these discrepancies are unclear, but may simply reflect differences
between mouse and rat, as well as differences in the VTA
subregions analyzed in these studies. Glutamatergic neurons have
also been identified in the VTA based on expression of the mRNA
for the vesicular glutamate transporter VGlut2 [49,50]. However,
according to Nair-Roberts et al. [46], glutamatergic neurons
account for only 2–3% of the total population of VTA neurons,
and they appear to be mainly enriched in medial parts of the
rostral VTA. Unfortunately, we are not aware of the existence of
immunohistochemical markers that allow unambiguous identifi-
cation of these glutamatergic neurons, therefore we could not
directly assess the expression of the a1 subunit in this neuronal
population.
Figure 3. Perisomatic and axodendritic innervation of DA and non-DA cells. (A) Representative confocal images showing perisomatic
innervation of TH-positive (left) and a1-positive cells (right) by GABAergic axonal boutons identified by VGAT immunoreactivity. The quantitative
analysis (B) revealed no difference in the density of perisomatic VGAT clusters between the two cell populations (type of cell, F(1,69):1.505, p = 0.224)
as well as between the rostral and caudal VTA (VTA subregion, F(1,69):1.175, p = 0.282; two-way ANOVA, n = 15–22 cells per group). (C) VGAT-positive
boutons contact dendritic profiles belonging to TH cells (left) or a1-positive cells (right). (D) The density of axo-dendritic innervation was significantly
higher for a1-positive cells than for TH cells (type of cell, F(1,119):64.409, p,0.001 ***), with no difference between rostral and caudal VTA (VTA
subregion, F(1,119):1.814, p = 0.181; two-way ANOVA, n = 23–38 fibers per group). Scale bar: 5 mm.
doi:10.1371/journal.pone.0046250.g003
Figure 4. Ubiquitous expression of GABABR1 in neurons of the
VTA. Triple labeling showing the expression of GABABR1 in both TH-
positive cells (left, arrows) and a1-positive neurons (right, asterisk). Note
that labeling for GABABR1 extends into the dendritic profiles of TH-
positive, but not a1-positive neurons. Scale bar: 30 mm.
doi:10.1371/journal.pone.0046250.g004
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The data discussed above are based on immunofluorescence
labeling of sections obtained from perfused brains. This methods
results in diffuse labeling of GABAAR subunits, which facilitates
cell visualization and colocalization analysis. By using a more
sensitive method, we found that a1-positive clusters were present
occasionally also at the surface of TH-positive cells, suggesting that
expression of a1-GABAARs is not uniquely restricted to non-DA
cells. This is in agreement with observations in the mouse VTA
[31], where diffuse labeling for the a1 subunit was found in about
7% of TH-positive cells, and also on a previous report according to
which DA cells can express the GABAAR a1 subunit mRNA [51].
Using our sensitive immunofluorescence protocol, we also found
that a3-positive clusters are present in both DA and non-DA cells
and that the a1 and a3 subunits can be co-localized at the same
synaptic hot spots (Fig. 1F,G). These results reveal a complex
organization of GABAARs in VTA neurons and may help explain
why GABAergic currents are reduced, but not abolished, in
midbrain DA cells of a3 knockout mice [52].
Previous studies have shown that GABAARs are more densely
located in non-DA cells than in DA neurons of the VTA
[23,53,54], and that activation of GABAARs in GABAergic cells
causes an increase of mesolimbic dopamine levels by relieving the
inhibitory, GABAergic input to DA neurons [23,27,31,53,54].
The differential expression of GABAARs in DA and non-DA cells
may explain the biphasic effects mediated by muscimol on the
release of DA. In fact, low doses of muscimol preferentially inhibit
GABAergic interneurons, resulting in disinhibition of DA cells,
whereas higher concentrations of muscimol inhibit DA neurons
[10,23,53]. These effects can be explained by the predominant
expression of a1-GABAARs in non-DA cells (ref. [31] and this
study), as well as by the differential GABAergic innervation
patterns of DA and non-DA cells (Fig. 3). Indeed, we found a
significantly higher density of GABAergic contacts in the dendritic
domains of a1-positive non-DA cells compared to DA neurons.
However, the density of perisomatic GABAergic synapes was
similar in the two populations of neurons. This may explain why
the frequency of mIPSCs was similar in GABAergic and DA cells
[31]. The largely differential expression of the a1 and a3 subunits
in DA and non-DA cells is predicted to affect the functional
properties of GABAergic inhibition. Indeed, Tan and colleagues
[31] reported that mIPSCs in VTA GABAergic neurons were
slower and bigger than those in DA neurons. This is surprising,
however, because a1-GABAARs are generally characterized by
fast decay kinetics that ensure fast synaptic inhibition [55–57]. It is
possible that additional factors, such as the co-expression of a1 and
a3 subunits (Fig. 1F,G) or the geometry of synaptic appositions
[58], may contribute to explain the unusual kinetics of a1-
GABAARs in non-DA cells. Another possibility is that the data
obtained by Tan et al. [31] were mainly derived from the
subgroup of non-DA neurons that have undetectable levels of the
a1 subunit (Table 2).
Another finding of the present study is the strong expression of
the GABABR1 subunit in both DA and non-DA cells of the rat
VTA (Fig. 4). The expression of GABABR1 was particularly
prominent in DA cells, that exhibited GABABR1 labeling in both
the somatic and dendritic compartment. This may be related to
previous observations according to which the majority of
GABABRs are located on DA neurons [10,59]. However, further
studies have shown that GABABRs are expressed in both DA and
GABA neurons, although different GABABR agonists exert
opposing effects on the reward system (see ref. [60] and references
therein). This differential effect is due to the much weaker coupling
between GABABRs and a G protein-gated, inwardly rectifying
potassium channel in DA cells compared to non-DA cells [60,61].
Because VTA interneurons provide inhibition to DA cells, they
are believed to play a crucial role in the control of DA release and
in the changes in VTA circuits that underlie addictive behaviors.
The present study contributes to our understanding of the
anatomy and neurochemical organization of GABAergic micro-
circuits of the VTA and lays the groundwork for future studies
examining the plasticity of GABAergic circuits induced by drug
exposure.
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